Boston Scientific Product Theater 4-24

Reducing Stroke Risk in your NVAF Patients: Is LAAC Elective or Essential?
Douglas N. Gibson, MD, Gwen S. Janczyk, PA, and Kristi C. Pangborn, NP

Saturday, April 24, 2021
12:30-1:30 p.m. PT


12:30 p.m.

Identification and Rationale of the Appropriate Patient for Left Atrial Appendance Closure (LACC)
Kristi C. Pangborn, NP

12:50 p.m.

Pre-Implant to Follow-up: Safety and Efficiencies in Patient Workflow
Gwen S. Janczyk, PA

1:10 p.m.

WATCHMAN FLX: New Innovations in LAAC Therapy for NVAF Patients
Douglas Gibson, MD

1:30 p.m.



Please note: all times listed are Pacific Standard Time (PDT).


April 15, 2021

Created by

Scripps CME Connection